| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 626 |
| 1 | PREDNISONE | 404 |
| 2 | INFLIXIMAB | 301 |
| 3 | METHOTREXATE SODIUM | 210 |
| 4 | VEDOLIZUMAB | 206 |
| 5 | METHYLPREDNISOLONE | 198 |
| 6 | METHOTREXATE | 192 |
| 7 | RITUXIMAB | 190 |
| 8 | ACETAMINOPHEN | 173 |
| 9 | METRONIDAZOLE | 173 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 10 | 0.0298 |
| 1 | INFLIXIMAB-DYYB | 52 | 0.0151 |
| 2 | SEROTONIN | 4 | 0.0147 |
| 3 | PHENAZOPYRIDINE HYDROCHLORIDE | 3 | 0.0091 |
| 4 | ACITRETIN | 44 | 0.0089 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 57 | 0.0068 |
| 6 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 2 | 0.0068 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 27 | 0.0059 |
| 8 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 2 | 0.0053 |
| 9 | CLINDAMYCIN PHOSPHATE | 26 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 854 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 575 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 391 |
| 3 | Interleukin-23 Antagonist [EPC] | 261 |
| 4 | Integrin Receptor Antagonist [EPC] | 235 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 226 |
| 6 | Platinum-based Drug [EPC] | 216 |
| 7 | Benzodiazepine [EPC] | 193 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 192 |
| 9 | Vitamin C [EPC] | 185 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 10 | 0.0122 |
| 1 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 2 | Provitamin D2 Compound [EPC] | 124 | 0.0042 |
| 3 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 4 | GLP-2 Analog [EPC] | 44 | 0.0033 |
| 5 | Integrin Receptor Antagonist [EPC] | 235 | 0.0027 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 174 | 0.0026 |
| 7 | Interleukin-23 Antagonist [EPC] | 261 | 0.0025 |
| 8 | Gamma Secretase Inhibitor [EPC] | 2 | 0.0022 |
| 9 | Endoglycosidase [EPC] | 4 | 0.0022 |